Literature DB >> 15018668

Yeast-expressed hantavirus Dobrava nucleocapsid protein induces a strong, long-lasting, and highly cross-reactive immune response in mice.

A Geldmacher1, M Schmaler, D H Krüger, R Ulrich.   

Abstract

In Europe, Dobrava virus (DOBV) carried by the yellow-necked field mouse Apodemus flavicollis is one of the hantaviruses that can cause severe hemorrhagic fever with renal syndrome in humans. For several hantaviruses, the nucleocapsid (N) protein has proven to be very immunogenic in humans and rodents and even can protect rodents against a virus challenge. To investigate the immunogenicity of DOBV N protein, BALB/c and C57BL/6 mice were immunized three times with a DOBV recombinant N (rN) protein expressed in yeast Saccharomyces cerevisiae together with complete Freund's, with incomplete Freund's, and without adjuvant, respectively. Mice of both strains elicited N-specific antibodies with end-point titers being as high as 1:1,000,000 in C57BL/6 mice. The antibodies induced by DOBV rN protein were highly cross-reactive to the rN proteins of hantaviruses Puumala and Hantaan. In both mice strains, DOBV rN protein induced N-specific antibodies of all IgG subclasses (IgG1, IgG2a, IgG2b, and IgG3), suggesting a mixed Th1/Th2 immune response. Taken together, yeast-expressed DOBV rN protein represents a promising vaccine candidate.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15018668     DOI: 10.1089/088282404322875511

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  11 in total

1.  Development of novel immunoglobulin G (IgG), IgA, and IgM enzyme immunoassays based on recombinant Puumala and Dobrava hantavirus nucleocapsid proteins.

Authors:  Helga Meisel; Anne Wolbert; Ausra Razanskiene; Andreas Marg; Andris Kazaks; Kestutis Sasnauskas; Georg Pauli; Rainer Ulrich; Detlev H Krüger
Journal:  Clin Vaccine Immunol       Date:  2006-10-04

2.  Specific humoral reaction of hemorrhagic fever with renal syndrome (HFRS) patients in China to recombinant nucleocapsid proteins from European hantaviruses.

Authors:  H-R Xiong; Q Li; W Chen; D-Y Liu; J-X Ling; J Liu; Y-J Liu; Y Zhang; Z-Q Yang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-01-08       Impact factor: 3.267

3.  Nucleocapsid protein of cell culture-adapted Seoul virus strain 80-39: analysis of its encoding sequence, expression in yeast and immuno-reactivity.

Authors:  Jonas Schmidt; Burkhard Jandrig; Boris Klempa; Kumiko Yoshimatsu; Jiro Arikawa; Helga Meisel; Matthias Niedrig; Christian Pitra; Detlev H Krüger; Rainer Ulrich
Journal:  Virus Genes       Date:  2005-01       Impact factor: 2.332

4.  Indirect immunofluorescence assay for the simultaneous detection of antibodies against clinically important old and new world hantaviruses.

Authors:  Sabine Lederer; Erik Lattwein; Merle Hanke; Karen Sonnenberg; Winfried Stoecker; Åke Lundkvist; Antti Vaheri; Olli Vapalahti; Paul K S Chan; Heinz Feldmann; Daryl Dick; Jonas Schmidt-Chanasit; Paula Padula; Pablo A Vial; Raluca Panculescu-Gatej; Cornelia Ceianu; Paul Heyman; Tatjana Avšič-Županc; Matthias Niedrig
Journal:  PLoS Negl Trop Dis       Date:  2013-04-04

5.  Crystal Structure of the Core Region of Hantavirus Nucleocapsid Protein Reveals the Mechanism for Ribonucleoprotein Complex Formation.

Authors:  Yu Guo; Wenming Wang; Yuna Sun; Chao Ma; Xu Wang; Xin Wang; Pi Liu; Shu Shen; Baobin Li; Jianping Lin; Fei Deng; Hualin Wang; Zhiyong Lou
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

Review 6.  Immune response during hantavirus diseases: implications for immunotherapies and vaccine design.

Authors:  Farides Saavedra; Fabián E Díaz; Angello Retamal-Díaz; Camila Covián; Pablo A González; Alexis M Kalergis
Journal:  Immunology       Date:  2021-03-18       Impact factor: 7.215

Review 7.  Progress on the Prevention and Treatment of Hantavirus Disease.

Authors:  Rebecca L Brocato; Jay W Hooper
Journal:  Viruses       Date:  2019-07-04       Impact factor: 5.048

8.  Recent advances in hantavirus molecular biology and disease.

Authors:  Islam T M Hussein; Abdul Haseeb; Absarul Haque; Mohammad A Mir
Journal:  Adv Appl Microbiol       Date:  2011       Impact factor: 5.086

Review 9.  Animal Models for the Study of Rodent-Borne Hemorrhagic Fever Viruses: Arenaviruses and Hantaviruses.

Authors:  Joseph W Golden; Christopher D Hammerbeck; Eric M Mucker; Rebecca L Brocato
Journal:  Biomed Res Int       Date:  2015-07-21       Impact factor: 3.411

Review 10.  Vaccines and Therapeutics Against Hantaviruses.

Authors:  Rongrong Liu; Hongwei Ma; Jiayi Shu; Qiang Zhang; Mingwei Han; Ziyu Liu; Xia Jin; Fanglin Zhang; Xingan Wu
Journal:  Front Microbiol       Date:  2020-01-30       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.